Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Jack Wright's publication output changed over time?
ScholarIQpublication output · 2021–2024
Output declined75% over the shown period — from 4 works in 2021 to 1 in 2024.
4
2
5
1
2021202220232024
What are the most-cited papers on Jack Wright?
ScholarIQmost cited works
Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
К. Ray Chaudhuri, Jean‐Philippe Azulay, Per Odin, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek Chaudhari, Juan Carlos Parra, Toru Yamazaki, Julia Oddsdottir, Jack Wright, Pablo Martínez‐Martín
Drugs - Real World Outcomes. 202488 CitationsOPEN ACCESS
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Irene A. Malaty, Pablo Martínez‐Martín, К. Ray Chaudhuri, Per Odin, Matěj Škorvánek, Joohi Jimenez‐Shahed, Michael J. Soileau, Susanna Lindvall, Josefa Domingos, Sarah Jones, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Koray Onuk, Lars Bergmann, Samira Femia, Michelle Y. Lee, Jack Wright, Angelo Antonini
BMC Neurology. 202246 CitationsOPEN ACCESS
Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States
Dee Lin, Kruti Joshi, Alexander Keenan, Jason F. Shepherd, Hollie Bailey, Mia Berry, Jack Wright, Sophie Meakin, Carmela Benson, Edward Kim
Frontiers in Psychiatry. 202141 CitationsOPEN ACCESS
Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States
Andrew Thach, Eddie Jones, Eric J. Pappert, James Pike, Jack Wright, Alexander Gillespie
BMC Neurology. 202127 CitationsOPEN ACCESS
Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection
Heather Fitzgerald, Jason F. Shepherd, Hollie Bailey, Mia Berry, Jack Wright, Maxine Chen
Neuropsychiatric Disease and Treatment. 202117 CitationsOPEN ACCESS
Related on ScholarIQ
Adelphi Group (United Kingdom)
Institution
Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
Paper
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Paper
Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States
Paper
Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States
Paper
Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection
Paper